Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDXK | O00764 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.34 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11450069 | 0.91 | PDXK (0.46) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL3761208 | 0.86 | PDXK (0.62) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL11700751 | 0.84 | ALDH1A1 (0.60) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL4016022 | 0.81 | KDM4E (0.61) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL2909398 | 0.81 | PDXK (0.61) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL11469014 | 0.80 | KDM4E (0.47) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL11449347 | 0.77 | KDM4E (0.56) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL4558720 | 0.77 | PDXK (0.51) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL3900653 | 0.75 | PDXK (0.50) | PDXKKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL5500541 | 0.74 | PDXK (0.49) | PDXKKDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2482852-A2 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | ThioMatrix Forschungs- und Beratungs GmbH (AT) | 2012-08-08 | — | — | EP | claimed |
| WO-2011039259-A2 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | THIOMATRIX FORSCHUNGS- UND BERATUNGS GMBH (AT) | 2011-04-07 | — | — | WO | claimed |
| EP-4380545-A1 | MUCOADHESIVE OCULAR DELIVERY SYSTEM FOR THE TREATMENT OF GLAUCOMA | Bioadhésive Ophthalmics (FR) | 2024-06-12 | — | — | EP | disclosed |
| US-20230056811-A1 | MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED ON PREACTIVATED THIOMERS | BIOADHESIVE OPHTHALMICS (FR) | 2023-02-23 | — | — | US | disclosed |
| WO-2023012239-A1 | MUCOADHESIVE OCULAR DELIVERY SYSTEM FOR THE TREATMENT OF GLAUCOMA | BIOADHESIVE OPHTHALMICS (FR) | 2023-02-09 | — | — | WO | disclosed |
| EP-4099979-A1 | MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED ON PREACTIVATED THIOMERS | Bioadhésive Ophthalmics (FR) | 2022-12-14 | — | — | EP | disclosed |
| WO-2021156435-A1 | MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED ON PREACTIVATED THIOMERS | BIOADHESIVE OPHTHALMICS (FR) | 2021-08-12 | — | — | WO | disclosed |
| US-10639377-B2 | Mucoadhesive polymers having vitamin B partial structures | THIOMATRIX FORSCHUNGS-UND BERATUNGS GMBH (AT) | 2020-05-05 | — | — | US | disclosed |
| US-10639377-B2 | Mucoadhesive polymers having vitamin B partial structures | THIOMATRIX FORSCHUNGS-UND BERATUNGS GMBH (AT) | 2020-05-05 | — | — | US | disclosed |
| EP-2482852-B1 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | THIOMATRIX FORSCHUNGS- UND BERATUNGS GMBH (AT) | 2017-11-22 | — | — | EP | disclosed |
| US-20150209434-A1 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | THIOMATRIX FORSCHUNGS UND BERATUNGS GMBH (AT) | 2015-07-30 | — | — | US | disclosed |
| US-20120225855-A1 | TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | ZHU BING-YAN (US) | 2012-09-06 | — | — | US | disclosed |
| US-20120225024-A1 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | YKK CORPORATION (JP) | 2012-09-06 | — | — | US | disclosed |
| US-20120225024-A1 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | YKK CORPORATION (JP) | 2012-09-06 | — | — | US | disclosed |
| EP-2482852-A2 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | ThioMatrix Forschungs- und Beratungs GmbH (AT) | 2012-08-08 | — | — | EP | disclosed |
| EP-2482852-A2 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | ThioMatrix Forschungs- und Beratungs GmbH (AT) | 2012-08-08 | — | — | EP | disclosed |
| CN-102596253-A | Mucoadhesive polymers containing vitamin B substructures | THIOMATRIX FORSCHUNGS UND BERATUNGS GMBH | 2012-07-18 | — | — | CN | disclosed |
| WO-2011039259-A3 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | THIOMATRIX FORSCHUNGS- UND BERATUNGS GMBH (AT) | 2011-10-20 | — | — | WO | disclosed |
| WO-2011039259-A2 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | THIOMATRIX FORSCHUNGS- UND BERATUNGS GMBH (AT) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011039259-A2 | MUCOADHESIVE POLYMERS HAVING VITAMIN B PARTIAL STRUCTURES | THIOMATRIX FORSCHUNGS- UND BERATUNGS GMBH (AT) | 2011-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120225855-A1 | TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | JAK2, JAK1, JAK3 | PDXK 216/4885KDM4E 2916/4885ALDH1A1 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.